Service Introduction

Reqbio launched the recombinant antibody rapid expression CRO service to meet the needs of early drug discovery and preclinical research. Through the 293/CHO high-throughput transient expression system, expression delivery can be completed within 1 week at the earliest.

At the same time, combined with Reqbio's antibody drug activity screening service platform, the biological activity of the recombinant antibody produced by expression can be tested.

Service Advantage

Fig 1. Antibody Expression Service Advantage

Service flow

Protocol design→gene synthesis→vector construction→cell preparation→rapid expression→affinity purification→delivery after quality control

Service Content

Case presentation

Ordering method

Mail：sales@reqbio.com